General Information of Drug (ID: DMNM9DZ)

Drug Name
Nepicastat oral Drug Info
Synonyms SYN117
Indication
Disease Entry ICD 11 Status REF
Post-traumatic stress disorder 6B40 Phase 2 [1]
Cross-matching ID
PubChem CID
9840545
CAS Number
CAS 170151-24-3
TTD Drug ID
DMNM9DZ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etamicastat DM71BZV Heart failure BD10-BD13 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dopamine beta hydroxylase (DBH) TTYIP79 DOPO_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT00641511) Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD). U.S. National Institutes of Health.
2 Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol. 1997 Aug;121(8):1803-9.
3 Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-beta-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. Drugs R D. 2010;10(4):225-42.